{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:29:09Z","timestamp":1784366949076,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","giejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastrointestinal Endoscopy"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.gie.2008.10.046","type":"journal-article","created":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T05:09:28Z","timestamp":1238044168000},"page":"e11-e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis"],"prefix":"10.1016","volume":"69","author":[{"given":"Cheol Woong","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Hwan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwang Ha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Sup","family":"Eum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Mi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geun Am","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Uk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il Doo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gie.2008.10.046_bib1","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/j.1572-0241.2007.01279.x","article-title":"Incidence rates of post-ERCP complications: a systematic survey of prospective studies","volume":"102","author":"Andriulli","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2008.10.046_bib2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0016-5107(04)00353-0","article-title":"Prevention of post-ERCP pancreatitis: a comprehensive review","volume":"59","author":"Freeman","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0016-5107(04)02013-9","article-title":"Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials","volume":"60","author":"Singh","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib4","first-page":"162","article-title":"Mechanisms involved in the onset of post-ERCP pancreatitis","volume":"3","author":"Pezzilli","year":"2002","journal-title":"JOP"},{"key":"10.1016\/j.gie.2008.10.046_bib5","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.gie.2007.02.055","article-title":"Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study","volume":"65","author":"Manes","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.gie.2006.10.030","article-title":"Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis","volume":"65","author":"Andriulli","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5107(00)70377-4","article-title":"Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis","volume":"51","author":"Andriulli","year":"2000","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJM199609263351302","article-title":"Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy: Italian Group","volume":"335","author":"Cavallini","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gie.2008.10.046_bib9","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/j.1572-0241.2003.07698.x","article-title":"Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis","volume":"98","author":"Masci","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2008.10.046_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-230X-8-6","article-title":"Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis","volume":"8","author":"Zheng","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gie.2008.10.046_bib11","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00464-007-9738-2","article-title":"Low-dose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial","volume":"22","author":"Barkay","year":"2008","journal-title":"Surg Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib12","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1136\/gut.2007.140756","article-title":"A meta-analysis of NSAIDs in the prevention of post-ERCP pancreatitis","volume":"57","author":"Elmunzer","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.gie.2008.10.046_bib13","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0016-5085(03)00384-6","article-title":"Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography","volume":"124","author":"Murray","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gie.2008.10.046_bib14","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1572-0241.2007.01165.x","article-title":"Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP","volume":"102","author":"Sotoudehmanesh","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2008.10.046_bib15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cgh.2007.12.032","article-title":"Allopurinol to prevent pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized placebo-controlled trial","volume":"6","author":"Romagnuolo","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gie.2008.10.046_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1067\/msy.2001.115827","article-title":"Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis","volume":"130","author":"Keck","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.gie.2008.10.046_bib17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00006676-200403000-00014","article-title":"Successful management of severe acute pancreatitis with multiple organ failure","volume":"28","author":"Mizuguchi","year":"2004","journal-title":"Pancreas"},{"key":"10.1016\/j.gie.2008.10.046_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1572-0241.2006.00380.x","article-title":"Risk factors for post-ERCP pancreatitis: a prospective multicenter study","volume":"101","author":"Cheng","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2008.10.046_bib19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5107(91)70740-2","article-title":"Endoscopic sphincterotomy complications and their management: an attempt at consensus","volume":"37","author":"Cotton","year":"1991","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib20","series-title":"The Asian-Pacific perspective: redefining obesity and its treatment","author":"WHO\/IASO\/IOTF","year":"2000"},{"key":"10.1016\/j.gie.2008.10.046_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/gut.40.1.80","article-title":"Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis","volume":"40","author":"Messmann","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.gie.2008.10.046_bib22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0016-5107(99)70387-1","article-title":"Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial","volume":"49","author":"Poon","year":"1999","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1067\/mge.2002.122614","article-title":"Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial","volume":"55","author":"Manolakopoulos","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0016-5107(04)02647-1","article-title":"High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial","volume":"61","author":"Katsinelos","year":"2005","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0016-5107(04)00159-2","article-title":"Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis","volume":"59","author":"Rabenstein","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1053\/gast.2001.21172","article-title":"Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography","volume":"120","author":"Deviere","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gie.2008.10.046_bib27","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1111\/j.1572-0241.2001.04092.x","article-title":"A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis","volume":"96","author":"Dumot","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2008.10.046_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0016-5107(02)70431-8","article-title":"Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial","volume":"56","author":"Andriulli","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib29","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.gie.2006.03.934","article-title":"Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis","volume":"64","author":"Thomopoulos","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1572-0241.2006.00959.x","article-title":"Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: a multicenter, placebo-controlled, randomized clinical trial","volume":"102","author":"Li","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2008.10.046_bib31","first-page":"374","article-title":"Effects of FUT-175, a new synthetic protease inhibitor on endotoxin-induced disseminated intravascular coagulation in rats","volume":"13","author":"Yoshikawa","year":"1983","journal-title":"Haemostasis"},{"key":"10.1016\/j.gie.2008.10.046_bib32","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1254\/jphs.92.420","article-title":"Nafamostat mesilate is an extremely potent inhibitor of human tryptase","volume":"92","author":"Mori","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.gie.2008.10.046_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1067\/mge.2001.117550","article-title":"Risk factors for post-ERCP pancreatitis: a prospective, multicenter study","volume":"54","author":"Freeman","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib34","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1016\/S0016-5107(02)70028-X","article-title":"Evidence-based assessment: patient, procedure, or operator factors associated with ERCP complications","volume":"56","author":"Aronson","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib35","first-page":"169","article-title":"Post-ERCP pancreatitis: patient and technique-related risk factors","volume":"3","author":"Freeman","year":"2002","journal-title":"JOP"},{"key":"10.1016\/j.gie.2008.10.046_bib36","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1055\/s-2003-42614","article-title":"Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis","volume":"35","author":"Masci","year":"2003","journal-title":"Endoscopy"},{"key":"10.1016\/j.gie.2008.10.046_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2000-138","article-title":"Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment","volume":"32","author":"Rabenstein","year":"2000","journal-title":"Endoscopy"},{"key":"10.1016\/j.gie.2008.10.046_bib38","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0016-5107(02)70112-0","article-title":"Risk factors for complications after performance of ERCP","volume":"56","author":"Vandervoort","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2008.10.046_bib39","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00006676-199105000-00013","article-title":"ERCP- and endoscopic sphincterotomy-induced pancreatitis","volume":"6","author":"Sherman","year":"1991","journal-title":"Pancreas"},{"key":"10.1016\/j.gie.2008.10.046_bib40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000200762","article-title":"Changes in pancreatic exocrine secretion with age: pancreatic exocrine secretion does decrease in the elderly","volume":"50","author":"Laugier","year":"1991","journal-title":"Digestion"},{"key":"10.1016\/j.gie.2008.10.046_bib41","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0016-5107(02)70351-9","article-title":"National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002","volume":"56","author":"Cohen","year":"2002","journal-title":"Gastrointest Endosc"}],"container-title":["Gastrointestinal Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016510708028411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016510708028411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:09:17Z","timestamp":1758038957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016510708028411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0016510708028411"],"URL":"https:\/\/doi.org\/10.1016\/j.gie.2008.10.046","relation":{},"ISSN":["0016-5107"],"issn-type":[{"value":"0016-5107","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis","name":"articletitle","label":"Article Title"},{"value":"Gastrointestinal Endoscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gie.2008.10.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}